NCT04043598View on ClinicalTrials.gov

Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage

NARecruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
Subarachnoid HemorrhageCritical IllnessInfusion FluidSodium Disorder
Interventions
DRUG

0.9% Sodium-chloride

We will compare two already established treatment protocols: the use of normal saline versus lactated Ringer's for fluid therapy in patients with subarachnoid hemorrhage.

DRUG

Ringer's Lactate

We will compare two already established treatment protocols: the use of normal saline versus lactated Ringer's for fluid therapy in patients with subarachnoid hemorrhage.

Trial Locations (3)

1205

RECRUITING

Department of Intensive Care Medicine, Geneva

3010

RECRUITING

Department of Intensive Care, Bern University Hospital and University of Bern, Bern, Switzerland, Bern

9007

RECRUITING

Department of perioperative Intensive Care Medicine, Sankt Gallen

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER